1887

Abstract

Twelve MAbs were generated by immunization of BALB/c mice with plasma-derived hepatitis B virus surface spherical antigen particles subtype ayw2 (HBsAg/ayw2 genotype D). Their epitopes were mapped by analysis of reactivity with plasma-derived HBsAg/ayw2 and HBsAg/adw2 (genotype A) in enzyme immunoassays and blots. Mapping was supported by nested sets of truncated preS2 proteins and preS2 peptides. Five antibodies were S domain-specific, seven were preS2-specific and 11 had a preference for genotype D. According to our data, group I of the three known epitope groups of preS2 has to be divided into IA and IB. Three preS2-specific MAbs forming the new group IA reacted with genotype D residues 3–15 which have not yet been described as an epitope region. IA antibodies strongly inhibited the binding of polymerized human serum albumin. Two antibodies (group II) reacted with the glycosylated N-terminal region of preS2 in plasma-derived HBsAg, but not with a preparation from transfected murine cells. One group III antibody was subtype-specific and reacted with the highly variable preS2 sequence 38–48. Only one antibody (group IB) mapped to the region (old group I) which was believed to be immunodominant and genotype-independent. Geno(sub)type-specific epitopes of preS2 are obviously the immunodominant components of natural HBsAg in BALB/c mice, but these epitopes may be masked by serum albumins in humans. The data may explain why it is difficult to detect anti-preS2 antibodies in human recipients of preS2-containing vaccines, in spite of the preS2 immunodominance in mice.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-2-369
2000-02-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/2/0810369a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-2-369&mimeType=html&fmt=ahah

References

  1. Berting, A., Hahnen, J., Kröger, M. & Gerlich, W. H. ( 1995; ). Computer-aided studies on the spatial structure of the small hepatitis B surface protein. Intervirology 38, 8-15.
    [Google Scholar]
  2. Bichko, V., Pushko, P., Dreilina, D., Pumpens, P. & Grens, E. ( 1985; ). Subtype ayw variant of hepatitis B virus: DNA primary structure analysis. FEBS Letters 185, 208-212.[CrossRef]
    [Google Scholar]
  3. Bruss, V., Lu, X., Thomssen, R. & Gerlich, W. H. ( 1994; ). Post-translational alterations in transmembrane topology of the hepatitis B virus envelope protein. EMBO Journal 13, 2273-2279.
    [Google Scholar]
  4. Carman, W. F., Jacyna, M. R., Hadziyannis, S., Karayiannis, P., McGarvey, M. J., Makris, A. & Thomas, H. C. (1989). Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588–591.
  5. Couillin, I., Pol, S., Mancini, M., Driss, F., Brechot, C., Tiollais, P. & Michel, M. L. ( 1999; ). Specific vaccine therapy in chronic hepatitis B: Induction of T-cell proliferative responses specific for envelope antigens. Journal of Infectious Diseases 180, 15-26.[CrossRef]
    [Google Scholar]
  6. Cupps, T. R., Tibbles, J., Hurni, W. M., Miller, W. J., Ellis, R. W., Milich, D. & Wetter, N. ( 1993; ). In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2+S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site. Journal of Immunology 15, 3353-3360.
    [Google Scholar]
  7. Ellis, R. W. (editor) (1991). Hepatitis B Vaccines in Clinical Practice. New York: Marcel Dekker.
  8. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P. & Charnay, P. ( 1979; ). Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646-650.[CrossRef]
    [Google Scholar]
  9. Ganem, D. ( 1991; ). Hepadnaviridae and their replication. In Fields Virology, pp. 2703-2737. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
  10. Gültekin, H. & Heermann, K. H. ( 1988; ). The use of polyvinylidenedifluoride membranes as a general blotting matrix. Analytical Biochemistry 172, 320-329.[CrossRef]
    [Google Scholar]
  11. Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H. & Gerlich, W. H. ( 1984; ). Large surface proteins of hepatitis B virus containing the pre-S sequence. Journal of Virology 52, 396-402.
    [Google Scholar]
  12. Heermann, K. H., Kruse, F., Seifer, M. & Gerlich, W. H. ( 1987; ). Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28, 14-25.[CrossRef]
    [Google Scholar]
  13. Heermann, K. H., Waldeck, F. & Gerlich, W. H. ( 1988; ). Interaction between native human serum and the preS2 domain of hepatitis B virus surface antigen. In Viral Hepatitis and Liver Disease, pp. 697-700. Edited by A. J. Zuckerman. New York: Alan R. Liss.
  14. Howard, C. R., Frew, A. F., D’Mello, F. & Stirk, H. ( 1991; ). Structure of HBV preS protein predicted by peptide scanning and computer modeling. In Viral Hepatitis and Liver Disease, pp. 254-257. Edited by F. Blaine Hollinger, S. Lemon & H. Margolis. Baltimore: Williams & Wilkins.
  15. Itoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakawa, Y. & Mayumi, M. ( 1986; ). A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proceedings of the National Academy of Sciences, USA 83, 9174-9178.[CrossRef]
    [Google Scholar]
  16. Janowicz, Z. A., Melber, K., Merckelbach, A., Jacobs, E., Harford, N., Comberbach, M. & Hollerberg, C. P. ( 1991; ). Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast 7, 431-443.[CrossRef]
    [Google Scholar]
  17. Kann, M. & Gerlich, W. H. (1998). Hepadnaviridae structure and molecular virology. In Viral Hepatitis, 2nd edn, chapter 7. Edited by A. J. Zuckermann & K. C. Thomas. New York: Churchill–Livingstone.
  18. Köchel, H. G., Schüler, A., Lottmann, S. & Thomssen, R. (1990). Sequence of cloned hepatitis B virus DNA isolate 991. EMBL accession number X51790.
  19. Köhler, G. & Milstein, C. ( 1975; ). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.[CrossRef]
    [Google Scholar]
  20. Köhler, G., Hengartner, H. & Shulman, M. J. ( 1978; ). Immunoglobulin production by lymphocyte hybridomas. European Journal of Immunology 8, 82-88.[CrossRef]
    [Google Scholar]
  21. Krone, B., Lenz, A., Heermann, K. H., Seifer, M., Lu, X. & Gerlich, W. H. ( 1990; ). Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology 11, 1050-1056.[CrossRef]
    [Google Scholar]
  22. Legler, K., Strohmeyer, H., Ritter, S., Gerlich, W. H. & Thomssen, R. ( 1983; ). Kinetics, subtype specificity and immunoglobulin class of anti-HBs induced by hepatitis B vaccine. Developments in Biological Standardization 54, 179-198.
    [Google Scholar]
  23. Machida, A., Kishimoto, S., Ohnuma, H., Baba, K., Ito, Y., Miyamoto, H., Funatsu, G., Oda, K., Usuda, S., Togami, S., Nakamura, T., Miyakawa, Y. & Mayumi, M. ( 1984; ). A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleotide acid bears the receptor of polymerized human as well as chimpanzee albumins. Gastroenterology 86, 910-918.
    [Google Scholar]
  24. Magnius, L. O. & Norder, H. ( 1995; ). Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38, 24-34.
    [Google Scholar]
  25. Meisel, H., Jantschak, J., Tars, K., Prosch, S., Pushko, P. & Pumpens, P. (1993). Complete nucleotide sequence of hepatitis B virus, subtype adw. EMBL accession number L13994.
  26. Meisel, H., Sominskaya, I., Pumpens, P., Pushko, P., Boriskova, G., Deepen, R., Lu, X., Spiller, G., Krüger, D., Grens, E. & Gerlich, W. H. ( 1994; ). Fine mapping and functional characterization of two immunodominant regions from the preS2 sequence of hepatitis B virus. Intervirology 37, 330-339.
    [Google Scholar]
  27. Milich, D. R. ( 1997; ). Pathobiology of acute and chronic hepatitis B virus infection: an introduction. Journal of Viral Hepatology 4, 25-30.[CrossRef]
    [Google Scholar]
  28. Milich, D. R., Thornton, G. B., Neurath, A. R., Kent, S. B., Michel, M. L., Tiollais, P. & Chisari, F. V. ( 1985; ). Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228, 1195-1199.[CrossRef]
    [Google Scholar]
  29. Milich, D. R., McLachlan, A., Chisari, L. V., Nakamura, T. & Thornton, G. B. ( 1987; ). Two distinct but overlapping antibody binding sites in the preS2 region of HBsAg localized within 11 continuous residues. Journal of Immunology 137, 2703-2710.
    [Google Scholar]
  30. Mimms, L. T., Floreani, M., Tyner, J. & Whitters, E. ( 1990; ). Discrimination of hepatitis B virus subtypes using monoclonal antibodies to the preS1 and preS2 domains of the viral envelope. Virology 176, 604-619.[CrossRef]
    [Google Scholar]
  31. Miskovsky, E., Gershman, K., Clements, M. L., Cupps, T., Calandra, G., Hesley, T., Loli, V., Ellis, R., Kniskern, P. & Miller, W. ( 1991; ). Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and preS2+S antigens. Vaccine 9, 346-350.[CrossRef]
    [Google Scholar]
  32. Naumann, H., Schaefer, S., Yoshida, C. F. T., Gaspar, A. M. C., Repp, R. & Gerlich, W. H. ( 1993; ). Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. Journal of General Virology 74, 1627-1632.[CrossRef]
    [Google Scholar]
  33. Neurath, A. R. & Kent, S. B. H. ( 1988; ). The pre-S region of hepadnavirus envelope proteins. Advances in Virus Research 34, 65-69.
    [Google Scholar]
  34. Neurath, A. R., Kent, S. B. H. & Strick, N. ( 1984; ). Localisation and chemical synthesis of a preS gene coded immunodominant epitope of hepatitis B virus. Science 224, 392-395.[CrossRef]
    [Google Scholar]
  35. Neurath, A. R., Kent, S. B., Parker, K., Prince, A. M., Strick, N., Brotman, B. & Sproul, P. ( 1986a; ). Antibodies to a synthetic peptide from the pre-S2 120–145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4, 35-37.[CrossRef]
    [Google Scholar]
  36. Neurath, A. R., Kent, S. B. H., Strick, N. & Parker, K. ( 1986b; ). Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.[CrossRef]
    [Google Scholar]
  37. Neurath, A. R., Adamowics, P., Kent, S. B. H., Riottot, M. M., Strick, N., Parker, K., Offensperger, W., Petit, M. A., Wahl, S. & Budkowska, A. ( 1986c; ). Characterization of monoclonal antibodies specific for the preS2 region of the hepatitis B envelope protein. Molecular Immunology 23, 991-997.[CrossRef]
    [Google Scholar]
  38. Peterson, D. L., Paul, D. A., Lam, J., Tribby, I. I. & Achord, D. T. ( 1984; ). Antigenic structure of hepatitis B surface antigen; identification of the ‘d’ subtype determinant and use of monoclonal antibodies. Journal of Immunology 132, 920.
    [Google Scholar]
  39. Pontisso, P., Petit, M. A., Bankowski, M. J. & Peeples, M. E. ( 1989; ). Human liver plasma membranes contain receptors for hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. Journal of Virology 63, 1981-1988.
    [Google Scholar]
  40. Prange, R. & Streeck, R. E. ( 1995; ). Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO Journal 14, 247-256.
    [Google Scholar]
  41. Schmitt, S., Glebe, D., Alving, K., Tolle, T., Linder, M., Linder, D., Peter-Katalinic, J., Gerlich, W. H. & Geyer, R. ( 1999; ). Analysis of the preS2 N- and O-glycans of the M surface protein from human hepatitis B virus. Journal of Biological Chemistry 274, 11945-11957.[CrossRef]
    [Google Scholar]
  42. Shouval, D., Ilan, Y., Adler, R., Deepen, R., Panet, A., Even-Chen, Z., Gorecki, M. & Gerlich, W. H. ( 1994; ). Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing preS1 and preS2 antigens as compared with conventional yeast-derived vaccines. Vaccine 12, 1453-1459.[CrossRef]
    [Google Scholar]
  43. Sominskaya, I., Bichko, V., Pushko, P., Dreimane, A., Snikere, D. & Pumpens, P. ( 1992; ). Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus. Immunology Letters 33, 169-172.[CrossRef]
    [Google Scholar]
  44. Thoma, H. A., Hemmerling, A. E., Koller, E. & Kapfer, G. ( 1990; ). Does PreS2 have the same effect in improving the HBV immune response as preS1? In Viral Hepatitis and Liver Disease, pp. 736-744. Edited by F. Blaine Hollinger, S. Lemon & H. Margolis. Baltimore: Williams & Wilkins.
  45. Tolle, T., Glebe, D., Linder, M., Linder, D., Schmitt, S., Geyer, R. & Gerlich, W. H. ( 1998; ). Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus. Journal of Virology 72, 9978-9985.
    [Google Scholar]
  46. Valenzuela, P., Quiroga, M., Zaldivar, J., Gray, P. & Rutter, W. J. ( 1981; ). The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In Animal Virus Genetics, pp. 57-70. Edited by B. N. Fields, R. Jaenisch & C. F. Fox. New York: Academic Press.
  47. Yu, M. W., Finlayson, J. S. & Shih, J. W. ( 1985; ). Interaction between various polymerized human albumins and hepatitis B surface antigen. Journal of Virology 55, 736-743.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-2-369
Loading
/content/journal/jgv/10.1099/0022-1317-81-2-369
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error